XML 46 R34.htm IDEA: XBRL DOCUMENT
v3.8.0.1

LICENSED TECHNOLOGY (Details Textual) | 1 Months Ended | 12 Months Ended
--- | --- | ---
May 26, 2017 USD ($) | Jan. 23, 2015 USD ($) | Dec. 31, 2017 USD ($) shares | Dec. 31, 2016 USD ($)
Other Commitment |  |  | $ 231,000 |
Licensed technology |  |  | 127,000 |
Amortization of Intangible Assets |  |  | $ 534,000 | $ 677,000
Abeona Therapeutics LLC [Member] |  |  |  |
Finite-Lived Intangible Asset, Useful Life |  |  | 20 years |
EB Agreement [Member] |  |  |  |
Number Of License Agreements Research And Development Arrangements |  |  | 2 |
Acestor Therapeutics LLC [Member] |  |  |  |
Equity Method Investment, Ownership Percentage | 80.00% |  |  |
License Costs | $ 5,000,000 |  |  |
Plasma Technologies, LLC [Member] |  |  |  |
License Costs |  | $ 1,000,000 |  |
Noncontrolling Interest, Ownership Percentage by Parent | 20.00% |  |  |
Other Commitment | $ 4,000,000 |  |  |
Finite-Lived Intangible Asset, Useful Life |  |  | 11 years |
Payable Due Licensor Non current |  |  | $ 4,000,000 |
Shares Issued For License Technology Payable | shares |  |  | 1,096,151 |

X
- Definition Amount of licensed technology. + References No definition available. + Details
Name: | abeo_LicensedTechnology
Namespace Prefix: | abeo_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Refers to the number of licensing agreements under research and development arrangements. + References No definition available. + Details
Name: | abeo_NumberOfLicenseAgreementsResearchAndDevelopmentArrangements
Namespace Prefix: | abeo_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount less current portion of payable due to licensor. + References No definition available. + Details
Name: | abeo_PayableDueLicensorNonCurrent
Namespace Prefix: | abeo_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition The number of shares to be issued in the future to settle a payable for licensed technology as of balance sheet date. + References No definition available. + Details
Name: | abeo_SharesIssuedForLicenseTechnologyPayable
Namespace Prefix: | abeo_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 45 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=98514028&loc=d3e3602-108585 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 50 -Paragraph 2 -Subparagraph (a)(2) -URI http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275 + Details
Name: | us-gaap_AmortizationOfIntangibleAssets
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 323 -SubTopic 10 -Section 50 -Paragraph 3 -Subparagraph (a)(1) -URI http://asc.fasb.org/extlink&oid=66011266&loc=d3e33918-111571 + Details
Name: | us-gaap_EquityMethodInvestmentOwnershipPercentage
Namespace Prefix: | us-gaap_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. + References No definition available. + Details
Name: | us-gaap_FiniteLivedIntangibleAssetUsefulLife
Namespace Prefix: | us-gaap_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Costs incurred and are directly related to generating license revenue. Licensing arrangements include, but are not limited to, rights to use a patent, copyright, technology, manufacturing process, software or trademark. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.2(e)) -URI http://asc.fasb.org/extlink&oid=63488584&loc=d3e20235-122688 + Details
Name: | us-gaap_LicenseCosts
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The parent entity's interest in net assets of the subsidiary, expressed as a percentage. + References No definition available. + Details
Name: | us-gaap_MinorityInterestOwnershipPercentageByParent
Namespace Prefix: | us-gaap_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Minimum amount of other commitment not otherwise specified in the taxonomy. Excludes commitments explicitly modeled in the taxonomy, including but not limited to, long-term and short-term purchase commitments, recorded and unrecorded purchase obligations, supply commitments, registration payment arrangements, leases, debt, product warranties, guarantees, environmental remediation obligations, and pensions. + References No definition available. + Details
Name: | us-gaap_OtherCommitment
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=abeo_AbeonaTherapeuticsLlcMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis=abeo_LicenseAgreementTerms2Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | dei_LegalEntityAxis=abeo_AcestorTherapeuticsLlcMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | dei_LegalEntityAxis=abeo_PlasmaTechnologiesLlcMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |